Dividend Channel
Free Dividend Report - Top Ranked Stocks

PARTNER NEWS:

Tue, Mar 12, 10:32 AM, Zacks
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
Regeneron (REGN) obtains FDA approval for Praluent as an adjunct to diet and other LDL-C, lowering therapies to include pediatric patients aged eight and older with HeFH.

Tue, Mar 12, 7:58 AM, Zacks
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
ASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with eczema, who have previously been treated with Dupixent but did not achieve an adequate response.

Featured MNV Articles:

NXPI Makes Notable Cross Below Critical Moving Average
Friday, April 19, 5:05 PM ET, by Market News Video Staff

In trading on Friday, shares of NXP Semiconductors NV (NXPI) crossed below their 200 day ...

Amerisafe (AMSF) Shares Cross Above 200 DMA
Friday, April 19, 5:05 PM ET, by Market News Video Staff

In trading on Friday, shares of Amerisafe Inc (AMSF) crossed above their 200 day moving ...

GlobalFoundries Larger Than S&P 500 Component Keysight Technologies
Friday, April 19, 5:05 PM ET, by Market News Video Staff

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component GlobalFoundries ...

Consolidated Edison Now #260 Largest Company, Surpassing PPG Industries
Friday, April 19, 5:05 PM ET, by Market News Video Staff

In the latest look at the underlying components of the S&P 500 ordered by largest ...

First Advantage Breaks Above 200-Day Moving Average - Bullish for FA
Friday, April 19, 5:05 PM ET, by Market News Video Staff

In trading on Friday, shares of First Advantage Corp (FA) crossed above their 200 day ...

By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts


Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2024, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.